Diabetes

Articles on this topic

Diabetic Cardiovascular Autonomic Neuropathy: How to Detect This Serious Diagnosis and Why Is It Dangerous?

Diabetic autonomic neuropathy can affect various organ systems. Cardiovascular autonomic…

27. 1. 2022 Source: Diabetes

New Antidiabetic Drugs in Cardiovascular Prevention in International Recommendations

Results from studies on new antidiabetic drugs showing cardiovascular (CV) benefits of…

20. 12. 2021 Source: Diabetes

Effect of Empagliflozin on Clinical Stability in Patients with Heart Failure and Reduced LV Ejection Fraction

Previous studies have shown that the oral antidiabetic drug empagliflozin reduces the risk of…

29. 10. 2021 Source: Diabetes

Echokardiografie_srdce_monitoring_kardiomyopatie_angina_pectoris_septum_venózní_hypertenze

Overlap of SGLT2 Inhibitors from Diabetology to Cardiology

As recent research shows, one of the modern groups of antidiabetic drugs -⁠ SGLT2 inhibitors,…

29. 10. 2021 Source: Diabetes

Reducing Cardiovascular Risk in Diabetics Through Hypertension Treatment

The presence of hypertension in patients with diabetes worsens overall cardiovascular (CV)…

21. 6. 2021 Source: Diabetes

diabetik_mereni_cukru_glukoza_cukrovka_diabetes

Diabetic Nephropathy and COVID-19: Fatal Connection?

People with diabetes and diabetic kidney disease exhibit higher mortality and risk of severe…

26. 4. 2021 Source: Diabetes

Diabetic Foot Syndrome: An Unpleasant Scare for Diabetics and Their Attending Doctors

Diabetic foot syndrome is a very serious complication of diabetes mellitus (DM). It often…

8. 3. 2021 Source: Diabetes

Diabetic Retinopathy: A Blind Diabetic as Proof of Serious Neglect of Prevention

Diabetic retinopathy is the most common cause of blindness in working-age patients in…

1. 3. 2021 Source: Diabetes

DPP4 Inhibitors in Chronic Kidney Disease and Their Potential to Protect Against Diabetic Nephropathy

Preclinical and clinical observations suggest that dipeptidyl peptidase 4 (DPP4) inhibitors might...

14. 12. 2020 Source: Diabetes

Patient with Diabetes: When to Follow Up and When to Refer to a Specialist?

It is most often the general practitioner (GP) who first diagnoses diabetes. Whether during…

6. 12. 2020 Source: Diabetes

Gliflozins in the Treatment of Type 2 Diabetes According to Current Recommendations SVL

Gliflozins are a relatively new group of antidiabetics with a specific mechanism of action. In…

24. 11. 2020 Source: Diabetes

Case Study with Voting: Intensification of Type 2 Diabetes Therapy in a Chronically Treated Patient. How to Proceed According to Current Recommendations?

We have prepared an interactive case study for you with a 70-year-old patient with decompensated...

12. 11. 2020 Source: Diabetes

kamaradky_seniorky_zeny_kavarna_volny_cas_radost

Desirable Side Effects of Antidiabetics

The days when diabetology was a field solely focused on normalizing blood sugar levels are…

6. 11. 2020 Source: Diabetes

leky_medikace_vyber_doporuceni_preskripce

Prescription Restrictions on Antidiabetics Authorized for Prescription by General Practitioners -⁠ Status as of October 2020

Diabetes mellitus (DM) has become an increasing problem worldwide in recent years. Long-term…

15. 10. 2020 Source: Diabetes

10 Properties and Benefits of Gliptins: How They Work and When to Prescribe Them

General practitioners can now prescribe oral antidiabetics from the group of gliptins to…

28. 8. 2020 Source: Diabetes

1 2 3

E-courses on this topic

Authors: Prof. MUDr. Martin Haluzík, DrSc., prof. MUDr. Vojtěch Melenovský, CSc., prof. MUDr. Vladimír Tesař, DrSc.

Course detail